Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-α, and CXCL-1

Journal of Leukocyte Biology - Tập 84 Số 3 - Trang 652-660 - 2008
Fernando Conte1, Christina Barja‐Fidalgo2, Waldiceu A. Verri3, Fernando Q. Cunha3, Giles A. Rae4, Carmen Penido1, Maria das Graças1
1Departamento de Farmacologia Aplicada, Farmanguinhos, Fundação Oswaldo Cruz , Rio de Janeiro , Brazil
2Departamento de Farmacologia, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil
3Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil
4Departamento de Farmacologia, Instituto de Biologia, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

Tóm tắt

AbstractEndothelins (ETs) are involved in inflammatory events, including pain, fever, edema, and cell migration. ET-1 levels are increased in plasma and synovial membrane of rheumatoid arthritis (RA) patients, but the evidence that ETs participate in RA physiopathology is limited. The present study investigated the involvement of ETs in neutrophil accumulation and edema formation in the murine model of zymosan-induced arthritis. Intra-articular (i.a.) administration of selective ETA or ETB receptor antagonists (BQ-123 and BQ-788, respectively; 15 pmol/cavity) prior to i.a. zymosan injection (500 μg/cavity) markedly reduced knee-joint edema formation and neutrophil influx to the synovial cavity 6 h and 24 h after stimulation. Histological analysis showed that ETA or ETB receptor blockade suppressed zymosan-induced neutrophil accumulation in articular tissue at 6 h. Likewise, dual blockade of ETA/ETB with bosentan (10 mg/kg, i.v.) also reduced edema formation and neutrophil counts 6 h after zymosan stimulation. Pretreatment with BQ-123 or BQ-788 (i.a.; 15 pmol/cavity) also decreased zymosan-induced TNF-α production within 6 h, keratinocyte-derived chemokine/CXCL1 production within 24 h, and leukotriene B4 at both time-points. Consistent with the demonstration that ET receptor antagonists inhibit zymosan-induced inflammation, i.a. injection of ET-1 (1–30 pmol/cavity) or sarafotoxin S6c (0.1–30 pmol/cavity) also triggered edema formation and neutrophil accumulation within 6 h. Moreover, knee-joint synovial tissue expressed ETA and ETB receptors. These findings suggest that endogenous ETs contribute to knee-joint inflammation, acting through ETA and ETB receptors and modulating edema formation, neutrophil recruitment, and production of inflammatory mediators.

Từ khóa


Tài liệu tham khảo

Inoue, 1989, The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes, Proc. Natl. Acad. Sci. USA, 86, 2863, 10.1073/pnas.86.8.2863

Bdolah, 1989, SRTX-d, a new native peptide of the endothelin/sarafotoxin family, FEBS Lett., 256, 1, 10.1016/0014-5793(89)81706-5

Arai, 1990, Cloning and expression of a cDNA encoding an endothelin receptor, Nature, 348, 730, 10.1038/348730a0

Sakurai, 1990, Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor, Nature, 348, 732, 10.1038/348732a0

Davenport, 2006, Endothelin, Handb. Exp. Pharmacol., 2006, 295, 10.1007/3-540-32967-6_9

Shah, 2007, Endothelins in health and disease, Eur. J. Intern. Med., 18, 272, 10.1016/j.ejim.2007.04.002

Schwarting, 1996, Endothelin-1 modulates the expression of adhesion molecules on fibroblast-like synovial cells (FLS), Scand. J. Rheumatol., 25, 246, 10.3109/03009749609069994

Filep, 1993, Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors, Br. J. Pharmacol., 109, 880, 10.1111/j.1476-5381.1993.tb13657.x

Sampaio, 2000, Participation of endogenous endothelins in delayed eosinophil and neutrophil recruitment in mouse pleurisy, Inflamm. Res., 49, 170, 10.1007/s000110050577

Speciale, 1998, Different endothelins stimulate cytokine production by peritoneal macrophages and microglial cell line, Immunology, 93, 109, 10.1046/j.1365-2567.1998.00391.x

Sampaio, 2000, Role of endothelins on lymphocyte accumulation in allergy, J. Leukoc. Biol., 67, 189, 10.1002/jlb.67.2.189

Zouki, 1999, Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor, Br. J. Pharmacol., 127, 969, 10.1038/sj.bjp.0702593

Goronzy, 2005, Rheumatoid arthritis, Immunol. Rev., 204, 55, 10.1111/j.0105-2896.2005.00245.x

Kuryliszyn-Moskal, 2006, A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis, Clin. Rheumatol., 25, 314, 10.1007/s10067-005-0007-2

Haq, 1999, Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis, J. Med., 30, 51

Vaudo, 2004, Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity, Ann. Rheum. Dis., 63, 31, 10.1136/ard.2003.007740

Andersson, 1999, Periarticular tissue levels of cytokine- and endothelin-1-like immunoreactivity during the course of antigen-induced arthritis in the rat, Inflamm. Res., 48, 491, 10.1007/s000110050492

Penido, 2006, Antiinflammatory effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on zymosan-induced arthritis in mice, Inflamm. Res., 55, 457, 10.1007/s00011-006-5161-8

Verri, 2008, IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice, Proc. Natl. Acad. Sci. USA, 105, 2723, 10.1073/pnas.0712116105

Verri, 2006, IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-γ, endothelin, and prostaglandin, Proc. Natl. Acad. Sci. USA, 103, 9721, 10.1073/pnas.0603286103

Meuser-Batista, 2008, Tissue Cell

Rosengren, 2003, Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay, Clin. Diagn. Lab. Immunol., 10, 1002

Van Meurs, 1997, Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: kinetics of stromelysin and IL-1 mRNA levels during arthritis, Rheumatol. Int., 16, 197, 10.1007/BF01330296

Miyasaka, 1992, Increased production of endothelin-1 in patients with inflammatory arthritides, Arthritis Rheum., 35, 397, 10.1002/art.1780350406

Rocha, 1999, Periarthritis promotes gait disturbance in zymosan-induced arthritis in rats, Inflamm. Res., 48, 485, 10.1007/s000110050491

Sampaio, 2004, Effects of endothelin ETA receptor antagonism on granulocyte and lymphocyte accumulation in LPS-induced inflammation, J. Leukoc. Biol., 76, 210, 10.1189/jlb.1003504

Piovezan, 1997, Endothelins potentiate formalin-induced nociception and paw edema in mice, Can. J. Physiol. Pharmacol., 75, 596, 10.1139/y97-057

Yuyama, 2004, Inhibitory effects of a selective endothelin-A receptor antagonist YM598 on endothelin-1-induced potentiation of nociception in formalin-induced and prostate cancer-induced pain models in mice, J. Cardiovasc. Pharmacol., 44, S479, 10.1097/01.fjc.0000166309.63808.5f

Sampaio, 1995, ETA receptor antagonists inhibit allergic inflammation in the mouse, J. Cardiovasc. Pharmacol., 26, S416, 10.1097/00005344-199526003-00122

Khatib, 1997, The mechanism of inhibition of endothelin-1-induced stimulation of DNA synthesis in rat articular chondrocytes, Mol. Cell. Endocrinol., 132, 25, 10.1016/S0303-7207(97)00121-4

Yoshida, 1998, Endothelin-1 production by human synoviocytes, Ann. Clin. Biochem., 35, 290, 10.1177/000456329803500215

Wharton, 1992, Autoradiographic localization and analysis of endothelin-1 binding sites in human synovial tissue, Arthritis Rheum., 35, 894, 10.1002/art.1780350807

Hültner, 2005, Mast cells and endothelin-1: a life-saving biological liaison?, Trends Immunol., 26, 235, 10.1016/j.it.2005.03.007

Maurer, 2004, Mast cells promote homeostasis by limiting endothelin-1-induced toxicity, Nature, 432, 512, 10.1038/nature03085

Metz, 2006, Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells, Am. J. Pathol., 169, 815, 10.2353/ajpath.2006.060037

Nigrovic, 2007, Synovial mast cells: role in acute and chronic arthritis, Immunol. Rev., 217, 19, 10.1111/j.1600-065X.2007.00506.x

Eklund, 2007, Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy, Immunol. Rev., 217, 38, 10.1111/j.1600-065X.2007.00504.x

Cronstein, 2006, The inflammatory process of gout and its treatment, Arthritis Res. Ther., 8

Bombini, 2004, Tumor necrosis factor-α mediates neutrophil migration to the knee synovial cavity during immune inflammation, Eur. J. Pharmacol., 496, 197, 10.1016/j.ejphar.2004.06.003

Lipsky, 2000, Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group, N. Engl. J. Med., 343, 1594, 10.1056/NEJM200011303432202

Kim, 2006, A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis, J. Exp. Med., 203, 829, 10.1084/jem.20052349

Guerrero, 2008, Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2, J. Leukoc. Biol., 83, 122, 10.1189/jlb.0207123

Shao, 2006, Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice, J. Immunol., 176, 6254, 10.4049/jimmunol.176.10.6254

Hata, 2004, Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice, J. Clin. Invest., 114, 582, 10.1172/JCI200421795

Van de Loo, 1995, Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis, Arthritis Rheum., 38, 164, 10.1002/art.1780380204

Vale, 2004, Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain, Br. J. Pharmacol., 143, 833, 10.1038/sj.bjp.0705999

Vale, 2006, Anti-nociceptive effect of thalidomide on zymosan-induced experimental articular incapacitation, Eur. J. Pharmacol., 536, 309, 10.1016/j.ejphar.2006.02.051

Elferink, 1994, Endothelin-induced activation of neutrophil migration, Biochem. Pharmacol., 48, 865, 10.1016/0006-2952(94)90356-5